The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Toshio Gotoh - One of the best experts on this subject based on the ideXlab platform.
-
long term outcome after placement of a Percutaneous Endoscopic Gastrostomy tube
Geriatrics & Gerontology International, 2008Co-Authors: Takanari Tokunaga, Tadahiko Kubo, Suhen Ryan, Muneo Tomizawa, Shinichi Yoshida, Koutarou Takagi, Kumiko Furui, Toshio GotohAbstract:Aim: To evaluate long-term survival and prognostic factors in patients who have undergone placement of a Percutaneous Endoscopic Gastrostomy tube. Methods: A retrospective analysis of all patients without malignancy who underwent Percutaneous Endoscopic Gastrostomy at Hanyu General Hospital during the period January 2001–December 2005. Results: A total of 198 patients (100 men, 98 women) were assessed. Median age was 78 years (range, 25–97 years). The primary diagnosis was a cerebrovascular disorder in 149 (75.3%) of the patients. Prior to placement, 120 (60.6%) had suffered pneumonia. Survival was 87.4% at 1 month, 67.8% at 3 months, 52.6% at 6 months, 38.1% at 1 year, 27.8% at 2 years and 22.3% at 3 years. Pneumonia was the most common cause of death during the follow-up period (91 of 140 patients, 65.0%). Cox's proportional hazards model showed independent predictors of mortality to be a low serum albumin concentration (≤2.9 g/dL) and history of pneumonia before the procedure. Conclusions: Mortality of patients who underwent Percutaneous Endoscopic Gastrostomy appears to be high. In particular, the long-term prognosis was poor for patients with hypoalbuminemia, and this procedure is probably not preferred for patients with recurrent aspiration pneumonia.
Federico Balzola - One of the best experts on this subject based on the ideXlab platform.
-
Percutaneous Endoscopic Gastrostomy: A long-term follow-up
Nutrition, 1997Co-Authors: Claudio Finocchiaro, Ambra Ferrari, L Todros, Giuseppe Rovera, A. Vuolo, Raspolli Galletti, Federico BalzolaAbstract:Percutaneous Endoscopic Gastrostomy (PEG) is the preferred method of long-term tube feeding, but only a few studies describe a long-term follow- up. The purpose of this study is to analyze the follow-up of PEG enteral feeding patients in the long term, and to report on the complication and survival rates. Between January 1991 and June 1995, we studied 136 patients (49% cancer and 51% non-cancer patients; male = 68%, female = 32%) after PEG insertion. One hundred twenty-eight patients had a long-term follow-up of over 31 d. The mean duration of PEG feeding was 277 ?? 358 d (range 31- 1590): 17% of patients returned to oral feeding, 34% continued enteral nutrition, and 49% died. Major complications occurred in 3% of the patients: 1 aspiration pneumonia, 1 subcutaneous abscess, 2 buried bumper syndrome. Minor complications arose in 14% of our cases: 8 tube blockages, 4 tube dislodgements, 6 site infections. For the whole group of 136 patients, survival probabilities after PEG insertion at 1, 6, 12, and 24 mo were 90.5%, 52%, 42%, and 35%, respectively. After 180 d, the difference in survival probabilities between cancer and non-cancer patients became significant (P < 0.02). Median survival probability was 64% for non-cancer and 39% for cancer patients, and this trend did not change over 2 y.
Lester J Peters - One of the best experts on this subject based on the ideXlab platform.
-
prospective study of Percutaneous Endoscopic Gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing chemo radiation
Head and Neck-journal for The Sciences and Specialties of The Head and Neck, 2009Co-Authors: June Corry, Wendy Poon, Narelle Mcphee, Alvin Milner, Deborah Cruickshank, Sandro V Porceddu, Danny Rischin, Lester J PetersAbstract:Background. Percutaneous Endoscopic Gastrostomy (PEG) tubes have largely replaced nasogastric tubes (NGTs) for nutritional support of patients with head and neck cancer undergoing curative (chemo) radiotherapy without any good scientific basis.
Benjamin S Bryner - One of the best experts on this subject based on the ideXlab platform.
-
safety and long term outcomes of Percutaneous Endoscopic Gastrostomy in patients with head and neck cancer
Surgical Endoscopy and Other Interventional Techniques, 2015Co-Authors: Richard E Burney, Benjamin S BrynerAbstract:Background Percutaneous Endoscopic Gastrostomy (PEG) is used for nutritional support during treatment in patients with head and neck cancer, but long-term nutritional outcomes have not been reported in detail. The purpose of this study was to determine short- and long-term outcomes and success in meeting nutritional goals in patients with head and neck cancer who had PEGs placed over an 18-year period.
Sandro V Porceddu - One of the best experts on this subject based on the ideXlab platform.
-
prospective study of Percutaneous Endoscopic Gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing chemo radiation
Head and Neck-journal for The Sciences and Specialties of The Head and Neck, 2009Co-Authors: June Corry, Wendy Poon, Narelle Mcphee, Alvin Milner, Deborah Cruickshank, Sandro V Porceddu, Danny Rischin, Lester J PetersAbstract:Background. Percutaneous Endoscopic Gastrostomy (PEG) tubes have largely replaced nasogastric tubes (NGTs) for nutritional support of patients with head and neck cancer undergoing curative (chemo) radiotherapy without any good scientific basis.
